BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 27109311)

  • 41. In vitro activity of synthetic tetrahydroindeno[2,1-c]quinolines on Leishmania mexicana.
    Hernández-Chinea C; Carbajo E; Sojo F; Arvelo F; Kouznetsov VV; Romero-Bohórquez AR; Romero PJ
    Parasitol Int; 2015 Dec; 64(6):479-83. PubMed ID: 26148815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neolignan Licarin A presents effect against Leishmania (Leishmania) major associated with immunomodulation in vitro.
    Néris PL; Caldas JP; Rodrigues YK; Amorim FM; Leite JA; Rodrigues-Mascarenhas S; Barbosa-Filho JM; Rodrigues LC; Oliveira MR
    Exp Parasitol; 2013 Oct; 135(2):307-13. PubMed ID: 23891943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro and in vivo efficacy of ether lipid edelfosine against Leishmania spp. and SbV-resistant parasites.
    Varela-M RE; Villa-Pulgarin JA; Yepes E; Müller I; Modolell M; Muñoz DL; Robledo SM; Muskus CE; López-Abán J; Muro A; Vélez ID; Mollinedo F
    PLoS Negl Trop Dis; 2012; 6(4):e1612. PubMed ID: 22506086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro antileishmanial activity and cytotoxicity of essential oil from Lippia sidoides Cham.
    de Medeiros Md; da Silva AC; Citó AM; Borges AR; de Lima SG; Lopes JA; Figueiredo RC
    Parasitol Int; 2011 Sep; 60(3):237-41. PubMed ID: 21421075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica.
    El Hajj R; Bou Youness H; Lachaud L; Bastien P; Masquefa C; Bonnet PA; El Hajj H; Khalifeh I
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006854. PubMed ID: 30462645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of photodynamic therapy using TiO
    Sepúlveda AAL; Arenas Velásquez AM; Patiño Linares IA; de Almeida L; Fontana CR; Garcia C; Graminha MAS
    Photodiagnosis Photodyn Ther; 2020 Jun; 30():101676. PubMed ID: 32001331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate.
    Shokri A; Sharifi I; Khamesipour A; Nakhaee N; Fasihi Harandi M; Nosratabadi J; Hakimi Parizi M; Barati M
    Parasitol Res; 2012 Mar; 110(3):1113-7. PubMed ID: 21847598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antileishmanial activity and cytotoxicity of Brazilian plants.
    Ribeiro TG; Chávez-Fumagalli MA; Valadares DG; Franca JR; Lage PS; Duarte MC; Andrade PH; Martins VT; Costa LE; Arruda AL; Faraco AA; Coelho EA; Castilho RO
    Exp Parasitol; 2014 Aug; 143():60-8. PubMed ID: 24846006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The leishmanicidal effect of Lucilia sericata larval saliva and hemolymph on in vitro Leishmania tropica.
    Rahimi S; Khamesipour A; Akhavan AA; Rafinejad J; Ahmadkhaniha R; Bakhtiyari M; Veysi A; Akbarzadeh K
    Parasit Vectors; 2021 Jan; 14(1):40. PubMed ID: 33430900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells.
    Mendez S; Traslavina R; Hinchman M; Huang L; Green P; Cynamon MH; Welch JT
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5114-21. PubMed ID: 19770283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antileishmanial Activity of Niosomal Combination Forms of Tioxolone along with Benzoxonium Chloride against Leishmania tropica.
    Parizi MH; Farajzadeh S; Sharifi I; Pardakhty A; Parizi MHD; Sharifi H; Salarkia E; Hassanzadeh S
    Korean J Parasitol; 2019 Aug; 57(4):359-368. PubMed ID: 31533402
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Silver nanoparticles and electroporation: Their combinational effect on Leishmania major.
    Dolat E; Rajabi O; Salarabadi SS; Yadegari-Dehkordi S; Sazgarnia A
    Bioelectromagnetics; 2015 Dec; 36(8):586-96. PubMed ID: 26769083
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monoterpenic aldehydes as potential anti-Leishmania agents: activity of Cymbopogon citratus and citral on L. infantum, L. tropica and L. major.
    Machado M; Pires P; Dinis AM; Santos-Rosa M; Alves V; Salgueiro L; Cavaleiro C; Sousa MC
    Exp Parasitol; 2012 Mar; 130(3):223-31. PubMed ID: 22227102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
    Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA
    Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aryl thiosemicarbazones: In vitro and immunomodulatory activities against L. amazonensis.
    da Silva AC; Dos Santos TAR; da Silva IVB; de Oliveira MVG; Moreira DRM; Leite ACL; Pereira VRA
    Exp Parasitol; 2017 Jun; 177():57-65. PubMed ID: 28433563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antileishmanial activities of caffeic acid phenethyl ester loaded PLGA nanoparticles against Leishmania infantum promastigotes and amastigotes in vitro.
    Abamor ES
    Asian Pac J Trop Med; 2017 Jan; 10(1):25-34. PubMed ID: 28107861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages.
    Borborema SE; Schwendener RA; Osso JA; de Andrade HF; do Nascimento N
    Int J Antimicrob Agents; 2011 Oct; 38(4):341-7. PubMed ID: 21783345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antileishmanial activity of the essential oil from Bixa orellana.
    Monzote L; García M; Scull R; Cuellar A; Setzer WN
    Phytother Res; 2014 May; 28(5):753-8. PubMed ID: 23983115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stachys lavandulifolia Vahl. exhibits promising in vitro and in vivo antileishmanial activity against Leishmania major infection.
    Alanazi AD; Albalawi AE; Almohammed HI; Shater AF
    Trop Biomed; 2022 Sep; 39(3):412-420. PubMed ID: 36214438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Formulation and Characterization of a Self-Emulsifying Drug Delivery System (SEDDS) of Curcumin for the Topical Application in Cutaneous and Mucocutaneous Leishmaniasis.
    Khan M; Nadhman A; Sehgal SA; Siraj S; Yasinzai MM
    Curr Top Med Chem; 2018; 18(18):1603-1609. PubMed ID: 30360717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.